NATCO Pharma Expands Strategic Investment in eGenesis to $24.70 Million to Support Next-Generation Xenotransplantation ...
NATCO Pharma Limited has announced an update regarding its ongoing investment in eGenesis, Inc. NATCO Pharma Limited has decided to increase its equity investment in eGenesis from the previously disclosed amount of US$14.00 million to US$16.70 million. …